Other languages TalkMed Group Limited

Equities

5G3

SG2G61000003

Market Closed - Singapore S.E. Other stock markets 09:59:47 30/04/2024 BST			5-day change	1st Jan Change
0.41 ^SGD	-2.38%		-1.20%	+7.89%

04-17	TalkMed Reaches Final Settlement in Mediation Related to Claims in Stem Med Stake Disposal	MT
03-14	TalkMed Group Awards 1.1 Million New Shares	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

TalkMed Group Limited Approves Final One-Tier Tax-Exempt Dividend for the Financial Year Ended 31 December 2023	04-18
TalkMed's H2 Attributable Profit Falls on Wider Impairment Loss	02-21
Talkmed Group Limited Proposes Tax Exempt (One-Tier) Final Dividend for the Financial Year Ended 31 December 2023, Payable on 10 May 2024	02-20
TalkMed Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	02-20
TalkMed Group Limited Announces Management Changes	11-10
TalkMed Group Limited Announces Re-Designation of Leong Ching Ching from Non-Executive Director to Independent Non-Executive Director and Appoints as Chairman of the Remuneration Committee, Effective January 1, 2024	11-10
TalkMed Group Limited Announces Re-Designation of S. Chandra Das from Independent Non-Executive Director to Non-Independent Non-Executive Director, Effective 1 January 2024	11-10
TalkMed Group Limited Announces Re-Designation of Sitoh Yih Pin from Independent Non-Executive Director to Non-Independent Non-Executive Director, Effective 1 January 2024	11-10
Talkmed Group Limited Appoints Khoo Kei Siong as Alternate Director to Ang Peng Tiam, Effective January 1, 2024	11-10
TalkMed Group Limited Appoints Dr Tan Khai Tong as Independent Non-Executive Director, Member of the Remuneration Committee, Effective January 1, 2024	11-10
TalkMed Group Limited Appoints Peter Sim Swee Yam as Independent Non-Executive Director, Chairman of the Nominating Committee, Member of the Audit and Risk Committee, Effective January 1, 2024	11-10
TalkMed Group Limited Appoints Lam Kok Shang as Independent Non-Executive Director, Chairman of the Audit and Risk Committee, Member of the Nominating Committee, Effective January 1, 2024	11-10
TalkMed Group Issues New Shares Upon Vesting of Share Awards	17/10/23
Singapore Stocks Track Global Gains to Close Higher; Delfi Shares Jump 3% on Higher H1 Profit, Revenue	08/08/23
TalkMed Group's Attributable Profit Zooms 18% in H1	08/08/23
TalkMed Group Limited Declares Tax Exempt (One-Tier) Interim Dividend for the Financial Year Ending 31 December 2023, Payable on 22 August 2023	07/08/23
TalkMed Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023	07/08/23
TalkMed Group Limited Approves the Final One-Tier Tax-Exempt Dividend in Respect of 2022	16/05/23
TalkMed Group Limited Proposes to Declare Final One-Tier Tax-Exempt Dividend for the Financial Year Ended 31 December 2022	05/04/23
TalkMed Group Issues Nearly 2 Million Shares Upon Vesting of Share Awards	14/03/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages TalkMed Group Limited

Equities

5G3

SG2G61000003

Other languages

Filters